Bharat Biotech has said on Tuesday that it is expecting regulatory approvals from the World Health Organisation (WHO) for its Covid-19 vaccine Covaxin by July-September 2021. The Hyderabad-based company stated that application for Emergency Use Listing (EUL) has been submitted to WHO, Geneva and regulatory approvals are expected by July-September 2021.

It also said regulatory approvals for Covaxin are in process in more than 60 countries including the United States, Brazil and Hungary. "Emergency use authorisations have been obtained in 13 countries with more to follow," it said. Most countries recommend vaccinations against Covid-19. Unvaccinated travellers can travel with negative RT-PCR tests prior to travel, in the absence of any other country specific travel restrictions, it added.